Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).
OBJECTIVE
For patients with severe, chronic limb ischemia in many cases interventional or surgical treatment is not possible anymore. In the past, both intramuscular and intraarterial transplantation of autologous BMCs had been proved therapeutically beneficial. The TAM-PAD study is the first one to analyze combined intraarterial and intramuscular BMC transplantation in its acute and long-term effects.


METHODS
13 patients with chronically ischemic limbs due to peripheral arterial disease (Fontaine stage IIb) were recruited and underwent follow-up examinations after 2 and 13 months. Mononuclear cells from bone marrow were injected intramuscular and intraarterial into the ischemic limb.


RESULTS
In contrast to the control group, after 2 months the pain-free walking distance of the transplanted patients significantly increased (from 147 +/- 90 to 500 +/- 614 m, p = 0.001). Furthermore the ankle-brachial index was significantly improved (at rest from 0.66+/-0.18 to 0.80+/-0.15, p = 0.003, after stress from 0.64 +/- 0.19 to 0.76 +/- 0.16, p = 0.006). Similar improvement was documented in capillary-venous oxygen-saturation (thigh from 59 +/- 9 to 66 +/- 5, p = 0.005, lower leg from 56 +/- 14 to 63 +/- 5, p = 0.021) and venous occlusion plethysmography (rest from 2.1 +/- 0.7 to 2.5 +/- 0.7, p = 0.009, mean reactive hyperemia from 5.3 +/- 1.8 to 7.2 +/- 1.8, p = 0.003, and peak flow from 7.2 +/- 3.2 to 10.8 +/- 2.8, p = 0.002). After 13 months these positive effects persisted at their improved level. No side effects or complications were monitored.


CONCLUSIONS
Combined intraarterial and intramuscular transplantation of autologous mononuclear bone marrow stem cells is a clinically feasible and minimally invasive therapeutic option for patients with severe chronic peripheral occlusive arterial disease.
Bartsch
T
T
Department of Medicine, Division of Cardiology Pneumology and Angiology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. Bartsch@med.uni-duesseldorf.de
Brehm
M
M
Zeus
T
T
Kögler
G
G
Wernet
P
P
Strauer
B E
BE
D000368:Aged; D018450:Disease Progression; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D018709:Statistics, Nonparametric; D014182:Transplantation, Autologous; D016896:Treatment Outcome
Ital Heart J Suppl. 2004 Jan;5(1):1-13
15253139
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9
11504914
J Vasc Surg. 2001 Dec;34(6):962-70
11743546
Nat Med. 1999 Dec;5(12):1359-64
10581076
Dtsch Med Wochenschr. 2006 Jan 20;131(3):79-83
16418945
Stem Cells. 2007 Feb;25(2):392-401
17038674
Circ Res. 2000 Jun 23;86(12):1198-202
10864908
Circulation. 2001 Feb 13;103(6):897-903
11171801
Lancet. 2002 Aug 10;360(9331):427-35
12241713
Ann Vasc Surg. 2005 Mar;19(2):241-7
15782270
Cardiovasc Res. 2005 Jun 1;66(3):543-51
15914119
Nat Med. 1999 Apr;5(4):434-8
10202935
Circulation. 2003 Feb 25;107(7):929-34
12600901
J Am Coll Cardiol. 2005 Nov 1;46(9):1651-8
16256864
Clin Res Cardiol. 2006 Dec;95(12):671-4
16967191
Cardiovasc Res. 2006 Mar 1;69(4):925-35
16409996
Nature. 2001 Apr 5;410(6829):701-5
11287958
Eur Heart J. 2005 Sep;26(18):1903-9
15855189
Blood. 2004 Dec 1;104(12):3472-82
15284120
Clin Res Cardiol. 2006 Jan;95(1):13-22
16598441
Dtsch Med Wochenschr. 2001 Aug 24;126(34-35):932-8
11523014
Circulation. 2002 Oct 8;106(15):1913-8
12370212